A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine
- 1 February 1994
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 46 (1), 35-39
- https://doi.org/10.1007/bf00195913
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clinical Pharmacokinetics of AlprazolamClinical Pharmacokinetics, 1993
- Fluvoxamine is a potent inhibitor of cytochrome P4501A2Biochemical Pharmacology, 1993
- Clinical Pharmacokinetics of Selective Serotonin Reuptake InhibitorsClinical Pharmacokinetics, 1993
- Single and Multiple Oral Dose Fluvoxamine Kinetics in Young and Elderly SubjectsTherapeutic Drug Monitoring, 1992
- Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effectsPsychopharmacology, 1987
- Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administrationPsychopharmacology, 1984
- Some Biochemical Correlates of Panic Attacks with Agoraphobia and Their Response to a New TreatmentJournal of Clinical Psychopharmacology, 1984
- SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF ORAL ALPRAZOLAM IN HEALTHY SMOKING AND NONSMOKING MEN1983
- Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled studyPsychopharmacology, 1982
- ALPRAZOLAM COMPARED TO DIAZEPAM AND PLACEBO IN THE TREATMENT OF ANXIETY1980